Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Phone-Based platform keep people in opioid treatment?

NCT ID NCT07810322

Disease control Sponsor: Duke University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 09, 2026 · Last updated Sep 10, 2026 · Updated 1 time

Summary

Researchers at Duke University are testing emPath, a digital platform that community outreach workers can use to connect adults with opioid use disorder to telemedicine visits and medication treatment. The pilot study enrolls 80 people in Durham, North Carolina, including 50 adults who screen positive for moderate to high risk opioid use and 10 outreach staff. The study measures whether participants stay in care and whether they and staff find the platform acceptable.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
emPath, a community-partnered telemedicine platform that offers registration, video visits, messaging, and low-barrier access to medication for opioid use disorder
What this could lead to
If the platform works, it could give outreach programs a practical way to connect people to opioid use disorder treatment and keep them engaged in care.
What could go wrong
This is a small pilot study of 80 people in one North Carolina county, so the results may not apply elsewhere. The study measures whether the platform is feasible and acceptable, not whether it improves health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for Outreach program PWOUD (n=50): * Age 18 or older * Screen positive for moderate to high risk opioid use by WHO-ASSIST * Not currently prescribed any form of MOUD * Able to speak and understand English * Able and willing to provide informed consent Inclusion Criteria for Outreach Staff (n=10): * Age 18 or older * Employed by the preceding 1 month or longer at time of enrollment * Able and willing to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Digital health intervention are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Digital health intervention Opioid-use disorder Outreach intervention Telemedicine

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Project MAPS (Mobile Addiction Treatment and Primary Care Services)

    RECRUITING

    Durham, North Carolina, 27703, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.